Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;17(9):1314-25.
doi: 10.15252/embr.201541724. Epub 2016 Jul 26.

Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition

Affiliations

Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition

Kohji Mori et al. EMBO Rep. 2016 Sep.

Abstract

Intronic hexanucleotide (G4C2) repeat expansions in C9orf72 are genetically associated with frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The repeat RNA accumulates within RNA foci but is also translated into disease characterizing dipeptide repeat proteins (DPR). Repeat-dependent toxicity may affect nuclear import. hnRNPA3 is a heterogeneous nuclear ribonucleoprotein, which specifically binds to the G4C2 repeat RNA We now report that a reduction of nuclear hnRNPA3 leads to an increase of the repeat RNA as well as DPR production and deposition in primary neurons and a novel tissue culture model that reproduces features of the C9orf72 pathology. In fibroblasts derived from patients carrying extended C9orf72 repeats, nuclear RNA foci accumulated upon reduction of hnRNPA3. Neurons in the hippocampus of C9orf72 patients are frequently devoid of hnRNPA3. Reduced nuclear hnRNPA3 in the hippocampus of patients with extended C9orf72 repeats correlates with increased DPR deposition. Thus, reduced hnRNPA3 expression in C9orf72 cases leads to increased levels of the repeat RNA as well as enhanced production and deposition of DPR proteins and RNA foci.

Keywords: C9orf72; dipeptide repeat proteins; frontotemporal lobar degeneration; hnRNPA3; neurodegeneration.

PubMed Disclaimer

Figures

Figure 1
Figure 1. hnRNPA3 modulates repeat RNA and poly‐GA expression
  1. A, B

    Knockdown of hnRNPA3 increases poly‐GA expression, while expressions of EGFP protein levels are not altered upon knockdown of hnRNPs. The control (“x0″) vector lacks the G4C2 repeats but still contains the 5′ flanking region and 3x TAG.

  2. C, D

    Overexpression of hnRNPA3 suppresses poly‐GA expression. n = 2 experiments performed in duplicates.

  3. E

    Increased repeat RNA upon hnRNPA3 knockdown. EGFP RNA levels are only slightly increased as compared to the levels of the repeat RNA. n = 2 experiments performed in duplicates.

  4. F, G

    Knockdown of hnRNPA3 increases RNA foci. n = 3 replicates; two‐tailed paired t‐test, Scale bar, 20 μm.

Data information: All graphs are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; two‐tailed paired t‐test (G), ANOVA with Dunnett's post‐test (B, E) or ANOVA with Tukey's post‐test (D).Source data are available online for this figure.
Figure 2
Figure 2. RNA binding and nuclear transport are required for hnRNPA3‐mediated repression of poly‐GA production
  1. A–C

    Rescue of repression of poly‐GA and repeat RNA by wild‐type (wt) hnRNPA3 and hnRNPA2 but not by the RNA binding mutant hnRNPA3DxD. (B) n = 3 experiments performed in duplicates; (C) n = 2 experiments performed in duplicates.

  2. D–F

    Rescue of repression of poly‐GA and repeat RNA by hnRNPA3WT but not the M9‐NLS deletion mutant. (E) n = 3 experiments performed in duplicates; (F) n = 4 experiments performed in duplicates.

Data information: All graphs are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 ANOVA with Tukey's post‐test. See also Fig EV1. Source data are available online for this figure.
Figure EV1
Figure EV1. hnRNPA3 modulates GA expression level
  1. A, B

    hnRNPA3 knockdown using an independent siRNA targeting hnRNPA3 (siA3#6) increases poly‐GA expression and is rescued by mCherry‐fused hnRNPA3. n = 4 experiments in duplicates.

  2. C

    Partial cytoplasmic distribution of mCherry‐hnRNPΔM9 lacking the M9 nuclear localization signal (NLS). mCherry‐fused hnRNPA3WT, its RNA binding mutant (DxD), and hnRNPA2 are almost completely nuclear. Scale bar, 10 μm. n = 2.

  3. D, E

    Double knockdown of hnRNPA3 and either hnRNPA1 or hnRNPA2 augments poly‐GA expression. n = 4 experiments in duplicates.

Data information: Graphs show mean ± SEM. *P < 0.05, ***P < 0.001; ANOVA with Dunnett's post‐test (B, E). Source data are available online for this figure.
Figure EV2
Figure EV2. High (G4C2)80 expression allows poly‐GA, poly‐GP, and poly‐GR production
  1. A

    Schematic representation of the repeat RNA expression constructs under the control of the strong CMV promoter.

  2. B

    (G4C2)80HIGH(+0) drives significantly more G4C2 repeat RNA transcription than that of the original (G4C2)80 construct, n = 3 experiments in duplicates. ***P < 0.001; ANOVA with Tukey's post‐test. Mean ± SEM are shown.

  3. C

    Upon transfection of the (G4C2)80HIGH(+0) construct, abundant poly‐GA protein was detected at the expected molecular weight together with insoluble aggregates that remained on the top of the gel as shown before 4. Asterisk indicates unspecific band.

  4. D, E

    All three sense DPRs show variable intracellular distribution upon transient transfection of one of the (G4C2)80HIGH constructs. Cells expressing relatively low amounts of GA show a diffuse GA distribution pattern (see E), whereas cells with high levels contain large cytoplasmic and/or nuclear GA aggregates. GP locates to the cytoplasm and nucleus and often co‐aggregates with GA. GR typically shows a diffuse cytoplasmic distribution. Expression and intracellular distribution pattern of each DPR appears is not affected by different TAGs. Scale bar, 10 μm. n = 3. (E) A large image visualizes frequent DPR expressions with various patterns. Scale bar, 20 μm.

Figure 3
Figure 3. DPR expression and deposition
  1. Poly‐GA aggregates co‐localize with p62‐positive deposits.

  2. Redistribution of nuclear TDP‐43 to the cytoplasm in a poly‐GA/poly‐GR double‐positive cell. Note that nuclei of poly‐GA/poly‐GR double‐positive cells are frequently disrupted.

  3. Knockdown of hnRNPA3 increases repeat RNA expression. n = 2 experiments performed in duplicates.

  4. Filter trap assay probed with anti‐FLAG, anti‐myc, or anti‐HA antibodies reveal abundant DPR production.

  5. Relative expression level of poly‐GA, poly‐GP, and poly‐GR normalized to GR. n = 3 experiments.

  6. Expression of all three DPRs is increased upon knockdown of hnRNPA3. Signals from knockdown with siRNA#8 were normalized to 1. n = 3 experiments.

  7. Co‐expression of two/three different DPRs in single cells is increased upon hnRNPA3 knockdown. n = 3 replicates.

Data information: All graphs are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; two‐tailed paired t‐test (G), ANOVA with Dunnett's post‐test (C, F, G) or ANOVA with Tukey's post‐test (E). Scale bars, 20 μm. See also Figs EV2 and EV3.
Figure EV3
Figure EV3. High (G4C2)80 expression results in strong DPR expression followed by TDP‐43 mislocalization
  1. Representative examples of endogenous TDP‐43 mislocalization in GA and GR co‐expressing cells. GA deposit‐positive but GR‐negative cell (arrow) shows normal TDP‐43 distribution (lowest panels). Nuclei were counterstained with DAPI. Scale bar, 10 μm.

  2. Poly‐GA and poly‐GR double‐positive cells frequently show increased mislocalization of endogenous TDP‐43. In three independent experiments, 697, 852, 287, 32, 767, 201, 40, 728, 207, and 64 cells per column were analyzed. ***P < 0.001; ANOVA with Tukey's post‐test. Mean ± SEM are shown.

Figure 4
Figure 4. Knockdown of hnRNPA3 induces neuronal DPR accumulation
Rat hippocampal neurons at DIV3 were transduced with lentivirus coexpressing either hnRNPA3 targeting shRNA (shA3) or a control shRNA (shCtrl) and tagRFP. Three days after transduction (DIV3 + 3), neurons were transfected with (G4C2)80HIGH(+0) and analyzed at (DIV3 + 7).
  1. Neurons were fixed, immunostained, and imaged by confocal microscopy. Double immunofluorescence for poly‐GA aggregates (green) and tagRFP (red). Nuclei were labeled with DAPI. Scale bar represents 20 μm.

  2. Efficient knockdown of endogenous rat hnRNPA3 with its targeting shRNA.

  3. Poly‐GA aggregates were detected in a filter trap assay using an anti‐Flag antibody.

  4. The amounts of poly‐GA aggregates were quantified and are presented as the fold change of signals from neurons treated with the control shRNA or the repeat construct. Means ± SD of three independent experiments are shown. *P < 0.05 by a Student's t‐test. n = 3 replicates.

Source data are available online for this figure.
Figure 5
Figure 5. Reduction of hnRNPA3 leads to enhanced formation of nuclear RNA foci in fibroblasts derived from patients with C9orf72 repeat extensions
  1. Fibroblasts from three individual patients with confirmed C9orf72 repeat expansions were investigated.

  2. Knockdown of hnRNPA3 with two independent siRNA results in selective depletion of hnRNPA3 in fibroblasts from 3 C9orf72 repeat carriers. Actin was used as a loading control.

  3. Knockdown of hnRNPA3 increases RNA foci in cells derived from C9orf72 carriers. No G4C2 repeat RNA foci are detected in fibroblasts without C9orf72 repeat expansions (WT). Nucleoli were stained with anti‐nucleolin antibodies (green), and nuclei were stained with DAPI (blue). Scale bar, 10 μm.

  4. Quantification of the relative frequency of RNA foci‐positive cells (RNA foci positivity; fold change). n = 3 experiments for each case. The average foci number of non‐treated (N/T) fibroblast was normalized to 1. Color code labels values obtained in fibroblasts derived from the three individual patients. Bars indicate mean, individual points indicate mean values obtained from a single experiment (49–214 cells were counted in a single experiment), and error bars indicate 95% CI. *P < 0.05, ***P < 0.001; ANOVA with Tukey–Kramer HSD test.

  5. Quantification of the number of RNA foci per RNA foci‐positive cell (fold change). n = 3 experiments for each case. The average foci number of non‐treated (N/T) fibroblast was normalized to 1. Color code labels values obtained in fibroblasts derived from the three individual patients. Bars indicate mean, individual points indicate mean values obtained from a single experiment (49–214 cells were counted in a single experiment), and error bars indicate 95% CI. *P < 0.05, **P < 0.01; ANOVA with Tukey–Kramer HSD test.

  6. Representative presentation of increased RNA foci in C9orf72 carriers upon lentiviral‐mediated hnRNPA3 knockdown. Scale bar, 10 μm.

  7. Quantification of the number of RNA foci (fold change). Three cases were analyzed. Single points indicate an average obtained from 29 to 30 cells per case. Color code labels values obtained in fibroblasts derived from the three individual patients. Mean ± SEM. **P < 0.01; two‐tailed t‐test.

Source data are available online for this figure.
Figure 6
Figure 6. Nuclear hnRNPA3 reduction correlates with poly‐GA accumulation in patients with C9orf72 repeat expansions
  1. Double immunofluorescence staining with anti‐GA (green) and anti‐hnRNPA3 (red) antibodies of the granular layer of the dentate gyrus of a control case and three C9orf72 mutation cases. In C9 mutation cases with low nuclear hnRNPA3 expression (#8 & #1), more poly‐GA aggregates were observed as in cases with high nuclear hnRNPA3 (#7). Inserts show examples of co‐localization of poly‐GA and hnRNPA3 aggregates. Scale bar, 10 μm.

  2. Granular layer neurons of a C9orf72 mutation case with (white arrows) or without (orange arrows) nuclear clearance of hnRNPA3. Scale bar, 10 μm.

  3. Poly‐GA aggregates are more frequent in C9orf72 mutation cases with lower nuclear hnRNPA3 levels than in those cases with higher nuclear hnRNPA3 levels (divided by median of nuclear hnRNPA3 intensities in 34 C9orf72 mutation cases into two subgroups). Bar graph indicates mean values. Error bars indicate 95% CI. Single points indicate mean from three micrographs per case. Note that the difference in GA positivity between both groups remains significant (P = 0.0086) after removal of the highest outlier in the low nuclear A3 group; two‐tailed t‐test.

Similar articles

Cited by

References

    1. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus‐Hernandez M, van Blitterswijk MM, Jansen‐West K, Paul JW 3rd, Rademakers R et al (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77: 639–646 - PMC - PubMed
    1. Gendron TF, Bieniek KF, Zhang YJ, Jansen‐West K, Ash PE, Caulfield T, Daughrity L, Dunmore JH, Castanedes‐Casey M, Chew J et al (2013) Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat‐associated non‐ATG translation in c9FTD/ALS. Acta Neuropathol 126: 829–844 - PMC - PubMed
    1. Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M et al (2013) Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 126: 881–893 - PubMed
    1. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C et al (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide‐repeat proteins in FTLD/ALS. Science 339: 1335–1338 - PubMed
    1. Zu T, Liu Y, Banez‐Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH et al (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A 110: E4968–E4977 - PMC - PubMed

Publication types

LinkOut - more resources